STRATA Skin Sciences Inc
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC exc… Read more
STRATA Skin Sciences Inc (SSKN) - Total Liabilities
Latest total liabilities as of September 2025: $29.40 Million USD
Based on the latest financial reports, STRATA Skin Sciences Inc (SSKN) has total liabilities worth $29.40 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
STRATA Skin Sciences Inc - Total Liabilities Trend (2002–2024)
This chart illustrates how STRATA Skin Sciences Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
STRATA Skin Sciences Inc Competitors by Total Liabilities
The table below lists competitors of STRATA Skin Sciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Armor Minerals Inc
PINK:RCZRF
|
USA | $16.38K |
|
Global Energy Ventures Ltd
PINK:GBBLF
|
USA | $792.81K |
|
Melon SA
SN:MELON
|
Chile | CL$178.18 Billion |
|
Xamble Group Ltd
AU:XGL
|
Australia | AU$2.12 Million |
|
SEMPRA ENERGY - Dusseldorf Stock Exchang
DU:SE4
|
Germany | €55.05 Billion |
Liability Composition Analysis (2002–2024)
This chart breaks down STRATA Skin Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 22.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.96 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how STRATA Skin Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for STRATA Skin Sciences Inc (2002–2024)
The table below shows the annual total liabilities of STRATA Skin Sciences Inc from 2002 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $31.18 Million | +6.33% |
| 2023-12-31 | $29.33 Million | -3.66% |
| 2022-12-31 | $30.44 Million | +43.73% |
| 2021-12-31 | $21.18 Million | +1.40% |
| 2020-12-31 | $20.89 Million | +11.75% |
| 2019-12-31 | $18.69 Million | +14.95% |
| 2018-12-31 | $16.26 Million | -0.78% |
| 2017-12-31 | $16.39 Million | -42.45% |
| 2016-12-31 | $28.47 Million | -19.30% |
| 2015-12-31 | $35.28 Million | +352.72% |
| 2014-12-31 | $7.79 Million | +33.55% |
| 2013-12-31 | $5.84 Million | +77.14% |
| 2012-12-31 | $3.29 Million | +107.74% |
| 2011-12-31 | $1.59 Million | -11.42% |
| 2010-12-31 | $1.79 Million | -1.15% |
| 2009-12-31 | $1.81 Million | +18.36% |
| 2008-12-31 | $1.53 Million | +14.50% |
| 2007-12-31 | $1.34 Million | +15.03% |
| 2006-12-31 | $1.16 Million | +26.78% |
| 2005-12-31 | $916.34K | -91.39% |
| 2004-12-31 | $10.65 Million | +1537.88% |
| 2003-12-31 | $650.00K | -87.00% |
| 2002-12-31 | $5.00 Million | -- |